Continuous veno-venous single-pass albumin hemodiafiltration in children with acute liver failure

Pediatric Critical Care Medicine

Volumn 12, Issue 3, 2011, Pages 257-264

  Ringe, Hannelore ^a   Varnholt, Verena ^a   Zimmering, Miriam ^b   Luck, Werner ^c   Gratopp, Alexander ^a   König, Kai ^a   Reich, Susanne ^a   Sauer, Igor M ^d   Gaedicke, Gerhard ^a   Querfeld, Uwe ^b  

^a Pediatric Interdisciplinary Intensive Care Unit   (Germany)

^b Department of Pediatric Nephrology ^*  (Germany)

^c Pediatric Gastroenterology   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

acute liver failure; albumin dialysis; childhood; hepatic encephalopathy; liver transplanation; veno venous single pass albumin hemodiafiltration

Indexed keywords

ADRENALIN; ALBUMIN; AMMONIA; BILE ACID; BILIRUBIN; FIBRINOGEN; FRESH FROZEN PLASMA; HEPARIN; HIRUDIN;

ACUTE LIVER FAILURE; ADOLESCENT; ALBUMIN DIALYSIS; ALLERGY; AMMONIA BLOOD LEVEL; ANTICOAGULANT THERAPY; ARTICLE; BILE ACID BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BLEEDING; CHILD; CHILD SAFETY; CHILDHOOD DISEASE; CHILDHOOD MORTALITY; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; FEMALE; FIBRINOGEN BLOOD LEVEL; HEALTH CARE COST; HEPARIN INDUCED THROMBOCYTOPENIA; HEPATIC ENCEPHALOPATHY; HUMAN; HYPERTENSION; HYPOTENSION; INTENSIVE CARE UNIT; LIVER TRANSPLANTATION; MALE; PATIENT SAFETY; PLEURA DISEASE; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SINGLE PASS ALBUMIN DIALYSIS; SURVIVAL RATE; THROMBOCYTE; THROMBOCYTE COUNT;

EID: 79955895572     PISSN: 15297535     EISSN: None     Source Type: Journal    
DOI: 10.1097/PCC.0b013e3181f35fa2     Document Type: Article

References (38)

1. Tissières P, Sasbón JS, Devictor D: Liver support for fulminant hepatic failure: Is it time to use the molecular adsorbents recycling system in children? Pediatr Crit Care Med 2005; 6:585-591 (Pubitemid 41306763)
2. Devictor D, Desplanques L, Debray D, et al: Emergency liver transplantation for fulminant liver failure in infants and children. Hepatology 1992; 16:1156-1162
3. Lee WS, McKiernan P, Kelly DA: Etiology, outcome and prognostic indicators of childhood fulminant hepatic failure in the United Kingdom. J Pediatr Gastroenterol Nutr 2005; 40:575-581 (Pubitemid 40617185)
4. Awad SS, Swaniker F, Magee J, et al: Results of a phase I trial evaluating a liver support device utilizing albumin dialysis. Surgery 2001; 130:354-362 (Pubitemid 32721691)
5. Kato T, Selvaggi G, Levi D, et al: Routine use of auxiliary partial orthotopic liver transplantation for children with fulminant hepatic failure: Preliminary report. Transplant Proc 2006; 38:3607-3608 (Pubitemid 44920242)
6. Noble-Jamieson G, Barnes N: Diagnosis and management of late complications after liver transplantation. Arch Dis Child 1999; 81: 446-451 (Pubitemid 29501384)
7. Morgan G, Superina RA: Lymphoproliferative disease after pediatric liver transplantation. J Pediatr Surg 1994; 29:1192-1196 (Pubitemid 24299577)
8. Novelli G, Rossi M, Pretagostini M, et al: One hundred sixteen cases of acute liver failure treated with MARS. Transplant Proc 2005; 37:2557-2559 (Pubitemid 41354668)
9. Novelli G, Rossi M, Morabito V, et al: Pediatric acute liver failure with molecular adsorbent recirculating system treatment. Transplant Proc 2008; 40:1921-1924
10. Markiewicz-Kijewska M, Szymczak M, Ismail H, et al: Liver transplantation for fulminant Wilson's disease in children. Ann Transplant 2008; 13:28-31
11. Stange J, Ramlow W, Mitzner S, et al: Dialysis against a recycled albumin solution enables the removal of albumin-bound toxins. Artif Organs 1993; 17:809-813 (Pubitemid 23288693)
12. Kortgen A, Rauchfuss F, Gö tz M, et al: Albumin dialysis in liver failure: Comparison of molecular adsorbent recirculating system and single pass albumin dialysis-a retrospective analysis. Ther Apher Dial 2009; 13: 419-425
13. Sauer IM, Goetz M, Steffen I, et al: In vitro comparison of the molecular adsorbent recirculation system (MARS) and single-pass albumin dialysis (SPAD). Hepatology 2004; 39:1408-1414 (Pubitemid 38569063)
14. Lu BR, Gralla J, Liu E, et al: Evaluation of a scoring system for assessing prognosis in pediatric acute liver failure. Clin Gastroenterol Hepatol 2008; 6:1140-1145
15. Covic A, Goldsmith DJ, Gusbeth-Tatomir P, et al: Successful use of Molecular Absorbent Regenerating System (MARS) dialysis for the treatment of fulminant hepatic failure in children accidentally poisoned by toxic mushroom ingestion. Liver Int 2003; 23(Suppl 3):21-27 (Pubitemid 37259216)
16. Shi Y, He J, Chen S, et al: MARS: Optimistic therapy method in fulminant hepatic failure secondary to cytotoxic mushroom poisoning-a case report. Liver 2002; 22(Suppl 2):78-80
17. Rubik J, Pietraszek-Jezierska E, Kamiński A, et al: Successful treatment of a child with fulminant liver failure and coma caused by Amanita phalloides intoxication with albumin dialysis without liver transplantation. Pediatr Transplant 2004; 8:295-300 (Pubitemid 38788558)
18. Prokurat S, Grenda R, Lipowski D, et al: MARS procedure as a bridge to combined liver-kidney transplantation in severe chromium- copper acute intoxication: A paediatric case report. Liver 2002; 22(Suppl 2): 76-77
19. Voiculescu M, Ioanitescu S, Rusu E, et al: Successful application of MARS therapy in a 7-year-old patient with hepatic chronic rejection and severe cholestatic syndrome. Rom J Gastroenterol 2002; 11:135-140 (Pubitemid 34728612)
20. Farmer DG, Venick RS, McDiarmid SV, et al: Fulminant hepatic failure in children: Superior and durable outcomes with liver transplantation over 25 years at a single center. Ann Surg 2009; 250:484-493
21. Binesh N, Huda A, Thomas MA, et al: Hepatic encephalopathy: A neurochemical, neuroanatomical, and neuropsychological study. J Appl Clin Med Phys 2006; 7:86-96
22. Sorkine P, Ben Abraham R, Szold O, et al: Role of the molecular adsorbent recycling system (MARS) in the treatment of patients with acute exacerbation of chronic liver failure. Crit Care Med 2001; 29:1332-1336 (Pubitemid 32641793)
23. Novelli G, Rossi M, Pretagostini R, et al: MARS (Molecular Adsorbent Recirculating System): Experience in 34 cases of acute liver failure. Liver 2002; 22(Suppl 2):43-47
24. Albrecht J, Dolińska M: Glutamine as a pathogenic factor in hepatic encephalopathy. J Neurosci Res 2001; 65:1-5 (Pubitemid 32601305)
25. Stewart CA, Cerhan J: Hepatic encephalopathy: A dynamic or static condition. Metab Brain Dis 2005; 20:193-204 (Pubitemid 41355609)
26. Novelli G, Rossi M, Pretagostini R, et al: A 3-year experience with Molecular Adsorbent Recirculating System (MARS): Our results on 63 patients with hepatic failure and color Doppler US evaluation of cerebral perfusion. Liver Int 2003; 23(Suppl 3):10-15 (Pubitemid 37259214)
27. Pugliese F, Ruberto F, Perrella SM, et al: Modifications of intracranial pressure after molecular adsorbent recirculating system treatment in patients with acute liver failure: Case reports. Transplant Proc 2007; 39: 2042-2044 (Pubitemid 47198824)
28. Nadalin S, Heuer M, Wallot M, et al: Paediatric acute liver failure and transplantation: The University of Essen experience. Transpl Int 2007; 20:519-527 (Pubitemid 46701079)
29. Stewart CA, Malinchoc M, Kim WR, Kamath PS: Hepatic encephalopathy as a predictor of survival in patients with end-stage liver disease. Liver Transpl 2007; 13:1366-1371 (Pubitemid 47629568)
30. Mitzner SR, Stange J, Klammt S, et al: Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: Results of a prospective, randomized, controlled clinical trial. Liver Transpl 2000; 6:277-286 (Pubitemid 30317221)
31. Butterworth RF: Role of circulating neurotoxins in the pathogenesis of hepatic encephalopathy: Potential for improvement following their removal by liver assist devices. Liver Int 2003; 23(Suppl 3):5-9 (Pubitemid 37259213)
32. Koivusalo AM, Teikari T, Hockerstedt K, Isoniemi H: Albumin dialysis has a favorable effect on amino acid profile in hepatic encephalopathy. Metab Brain Dis 2008; 23: 387-398
33. Pares A, Deulofeu R, Cisneros L, et al: Albumin dialysis improves hepatic encephalopathy and decreases circulating phenolic aromatic amino acids in patients with alcoholic hepatitis and severe liver failure. Crit Care 2009; 13:R8
34. Di Campli C, Zocco MA, Gaspari R, et al: The decrease in cytokine concentration during albumin dialysis correlates with the prognosis of patients with acute on chronic liver failure. Transplant Proc 2005; 37: 2551-2553 (Pubitemid 41354666)
35. Liu Q, Liu Z, Dalakas E: Prevalence of porcine endogenous retrovirus in Chinese pig breeds and in patients treated with a porcine liver cell-based bioreactor. World J Gastroenterol 2005; 11:4727-4730 (Pubitemid 41179531)
36. Aizaki H, Nagamori S, Matsuda M, et al: Production and release of infectious hepatitis C virus from human liver cell cultures in the three-dimensional radial-flow bioreactor. Virology 2003; 314:16-25 (Pubitemid 37153297)
37. Pless G, Sauer IM: Bioartificial liver: Current status. Transplant Proc 2005; 37:3893-3895 (Pubitemid 43015204)
38. Steiner C, Mitzner S: Experiences with MARS liver support therapy in liver failure: Analysis of 176 patients of the International MARS Registry. Liver 2002; 22(Suppl 2):20-25